Premium
Methylphenidate for ASD: Cochrane looks at evidence of effectiveness and safety
Author(s) -
Knopf Alison
Publication year - 2018
Publication title -
the brown university child and adolescent behavior letter
Language(s) - English
Resource type - Journals
eISSN - 1556-7575
pISSN - 1058-1073
DOI - 10.1002/cbl.30265
Subject(s) - methylphenidate , autism spectrum disorder , psychiatry , cochrane collaboration , psychology , autism , medicine , attention deficit hyperactivity disorder , clinical psychology , meta analysis , cochrane library
Short‐term use of methylphenidate could improve hyperactivity, and possibly inattention, in children with autism spectrum disorder (ASD), in children who are tolerant of the medication, according to a recent Cochrane Review . However, the researchers concluded there is no evidence to prove that methylphenidate for ASD in general is safe or effective.